Skip to content
APDN Announces Receipt of Linea™ DNA Follow-On Order for Cancer Diagnostic Application
November 28, 2023
Read More email
APDN Launches Initiatives to Expand Awareness of LinearDNA™ Platform as an Alternative to Plasmid DNA for Therapeutic Applications, Revamps LineaRx Website
June 29, 2022
Read More email
Positive Preclinical Data for LinearDNA™ as Novel Cancer Vaccine Strategy
June 7, 2022
Read More email
Research Publication Demonstrates Utility of APDN’s LinearDNA™ in Non-Viral CAR T Manufacturing Systems
November 9, 2021
Read More email
APDN and Takis Report Positive Preclinical Results from LineaDNA™ Vaccine Candidates for COVID-19
July 17, 2020
Read More email
LineaRx Receives Multiple Orders for Linear DNA for Use in Therapeutic Development
July 1, 2019
Read More email
LineaRx to Support Therapy Development for Neurodegenerative Diseases
June 26, 2019
Read More email
LineaRx Achieves Higher Expression and Survival Rates in Human T Cells
April 29, 2019
Read More email
LineaRx to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy
December 4, 2018
Read More email
LineaRx Licenses CAR T Drug Candidate, Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16, 2018
Read More email
APDN Forms Subsidiary, LineaRx, to Develop DNA for Biotherapeutics
September 18, 2018
Read More email
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok 
